Novantrone
Active Ingredient(s): MitoxantroneFDA Approved: * December 23, 1987
Pharm Company: * SERONO INC
Category: Cancer
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Novantrone Overview
Mitoxantrone (INN, BAN, USAN; also known as Mitozantrone in Australia; trade name Novantrone) is an anthracenedione antineoplastic agent. Contents 1 Uses 2 Side effects 3 Mechanism of action 4 See also 5 References Uses Mitoxantrone is used to treat certain types of cancer, mostly acute myeloid leukemia. It improves the survival rate of children suffering from acute lymphoblastic leukemia relapse.[1] The combination of mitoxantrone and prednisone is approved as a second...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Mitoxantrone
Recent Novantrone Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Mitoxantrone
- Injection: 20mg/10ml (2mg/ml), 20mg/10ml(2mg/ml), 25mg/12.5ml (2mg/ml), 2mg/ml, 30mg/15ml (2mg/ml)